H.C. Wainwright Reiterates Buy Rating on Barinthus Biotherapeutics (BRNS)

Go back to H.C. Wainwright Reiterates Buy Rating on Barinthus Biotherapeutics (BRNS)
(NASDAQ: BRNS) Delayed: 0.60 +0.02 (3.45%)
Previous Close $0.58    52 Week High
Open $0.58    52 Week Low
Day High $0.60    P/E N/A 
Day Low $0.56    EPS
Volume 7,108